YCM
MRVI icon

Yost Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Yost Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$410K Buy
+126,056
New +$424K 0.59% 13

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Yost Capital Management's MRVI Position: Q4 2025 in Review

Yost Capital Management opened a new position in Maravai LifeSciences (MRVI) in Q4 2025: 126,056 shares worth $410K. The stake represents 0.59% of the portfolio and ranks #13 among its holdings.

159 funds tracked by Wall St. Rank hold MRVI as of Q4 2025.

  • Yost Capital Management held 126,056 shares of Maravai LifeSciences worth $410K as of Q4 2025.
  • Maravai LifeSciences was a new Yost Capital Management position in Q4 2025.
  • Maravai LifeSciences made up 0.59% of Yost Capital Management's portfolio in Q4 2025, its #13 holding.
  • 159 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2025.

Based on Yost Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.